TGTX Jan 2025 22.000 call
| Previous close | 2.6500 |
| Open | 2.6500 |
| Bid | 2.5500 |
| Ask | 2.8500 |
| Strike | 22.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.6500 - 2.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.03k |
Investor's Business DailyStocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area
Among the best stocks to watch, biotech leader TG Therapeutics is clearing a key resistance area on the stock market today.
GuruFocus.comInsider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
On June 20, 2024, Director Sagar Lonial executed a significant transaction by selling 25,933 shares of TG Therapeutics Inc (NASDAQ:TGTX). The shares were sold at a price of $16.69 each, as detailed in the SEC Filing. Following this transaction, the insider now owns 105,195 shares of the company.
GlobeNewswireTG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Fireside chat scheduled for Tuesday, June 11, 2024, at 1:20 PM ETNEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, being held at the Loews Miami Beach Hotel, Miami Beach, FL on June 10-13, 2024. The fireside chat is scheduled to take place on Tuesday, June 11, 2024, at 1:20 PM ET. A live webcast o
